DelMar Pharmaceuticals has entered into a multi-year collaboration with Dr. Madan Kwatra, Director of the Glioblastoma Drug Discovery Group at …
Monthly Archives: April 2017
Press Release: AstraZeneca Grants Award to Develop Osimertinib for EGFRvIII-Positive Glioblastoma
Dr. Madan Kwatra, Director of the Glioblastoma Drug Discovery Group at Duke, has been awarded a $97,109 grant for his …